These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

72 related items for PubMed ID: 3750255

  • 1. [Pharmacokinetics of ranitidine in cirrhotic patients with or without ascites].
    Reymann JM, Richard MO, Bretagne JF, Allain H, Bentue-Ferrer D, D'Athis P, Van den Driessche J.
    Therapie; 1986; 41(3):173-8. PubMed ID: 3750255
    [No Abstract] [Full Text] [Related]

  • 2. Oral and intravenous pharmacokinetics of ranitidine in patients with liver cirrhosis.
    Okolicsanyi L, Venuti M, Strazzabosco M, Orlando R, Nassuato G, Iemmolo RM, Lirussi F, Muraca M, Pastorino AM, Castelli G.
    Int J Clin Pharmacol Ther Toxicol; 1984 Jun; 22(6):329-32. PubMed ID: 6086536
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Pharmacokinetics and bioavailability of ranitidine in normal subjects and cirrhotic patients.
    Morichau-Beauchant M, Houin G, Mavier P, Alexandre C, Dhumeaux D.
    Dig Dis Sci; 1986 Feb; 31(2):113-8. PubMed ID: 3943439
    [Abstract] [Full Text] [Related]

  • 6. The pharmacokinetics of H2 receptor blocking agents in compensated liver cirrhosis.
    Okolicsányi L, Venuti M, Strazzabosco M, Iemmolo RM, Nassuato G, Orlando R, Lirussi F.
    Acta Physiol Hung; 1984 Feb; 64(3-4):393-400. PubMed ID: 6099684
    [Abstract] [Full Text] [Related]

  • 7. Ranitidine disposition and systemic availability in hepatic cirrhosis.
    Smith IL, Ziemniak JA, Bernhard H, Eshelman FN, Martin LE, Schentag JJ.
    Clin Pharmacol Ther; 1984 Apr; 35(4):487-94. PubMed ID: 6323087
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Intestinal permeability in cirrhotic patients with and without ascites.
    Kalaitzakis E, Johansson JE, Bjarnason I, Björnsson E.
    Scand J Gastroenterol; 2006 Mar; 41(3):326-30. PubMed ID: 16497621
    [Abstract] [Full Text] [Related]

  • 11. [Metabolism and kinetics of ampicillin elimination in cirrhosis. Therapeutical consequences (author's transl)].
    Chalas J, Labayle D, Macarrio J, Barraud D, Lindenbaum A, Buffet C, Chaput JC.
    Sem Hop; 2006 Mar; 56(9-10):464-9. PubMed ID: 6244668
    [Abstract] [Full Text] [Related]

  • 12. Effects of ursodeoxycholic acid on systemic, renal and forearm haemodynamics and sodium homoeostasis in cirrhotic patients with refractory ascites.
    Wong F, Bomzon A, Allard J, Liu P, Blendis L.
    Clin Sci (Lond); 1999 May; 96(5):467-74. PubMed ID: 10209078
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Acute effects of the oral administration of midodrine, an alpha-adrenergic agonist, on renal hemodynamics and renal function in cirrhotic patients with ascites.
    Angeli P, Volpin R, Piovan D, Bortoluzzi A, Craighero R, Bottaro S, Finucci GF, Casiglia E, Sticca A, De Toni R, Pavan L, Gatta A.
    Hepatology; 1998 Oct; 28(4):937-43. PubMed ID: 9755229
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Pharmacokinetics of cefotaxime in cirrhotic patients with or without ascites].
    Vincent P, Colombel JF, Husson MO, Izard D, Paris JC, Leclerc H.
    Presse Med; 1988 Dec 10; 17(44):2331-4. PubMed ID: 2974968
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The influence of ascites on the pharmacokinetics of piretanide in cirrhotic patients.
    Shepherd AN, Bouchier IA.
    Eur J Clin Pharmacol; 1985 Dec 10; 28(5):581-3. PubMed ID: 4043200
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.